Renaud de Beaurepaire1*, Mathis Heydtmann2 and Roberta Agabio3 1Groupe Hospitalier Paul-Guiraud, Villejuif, France 2Department of Gastroenterology, Royal Alexandra Hospital Paisley, Paisley, United Kingdom 3Section of Neuroscience and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy Editorial on… Lire la suite
Tailored-Dose Baclofen in the Management of Alcoholism: A Retrospective Study of 144 Outpatients Followed for 3 Years in a French General Practice
Front. Psychiatry, 08 October 2018 | https://doi.org/10.3389/fpsyt.2018.00486 Juliette Pinot1*, Laurent Rigal2, Bernard Granger3, Stéphanie Sidorkiewicz1 and Philippe Jaury1 1Département de Médecine Générale, Université Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine, Paris, France 2Département de Médecine Générale, Université Paris Sud,… Lire la suite
Traitement par le baclofène de la boulimie nerveuse et de l’hyperphagie : une enquête Internet
Traduction en français de l’article : Baclofen treatment of bulimia nervosa and binge eating disorder an Internet survey Résumé Objectifs: La Boulimie Nerveuse (BN) et l’hyperphagie (BED) sont des pathologies difficiles à traiter et pour lesquelles il existe très peu… Lire la suite
Drug and Alcohol Findings
From Germany the first trial to rigorously test high doses of the muscle relaxant baclofen for the treatment of dependent drinking found post-detoxification drinking reductions of a magnitude rarely seen; safety issues remain, but it seems these can be managed… Lire la suite
The use of very high-doses of baclofen for the treatment of alcohol-dependence: a case series
Dr Renaud de Beaurepaire – Groupe Hospitalier Paul-Guiraud, Villejuif, France – Frontiers in Psychiatry – 10 ocotobre 2014 Baclofen, particularly high-dose baclofen, has recently emerged as a treatment of major interest for alcohol-dependence. However, baclofen has many potentially dangerous side… Lire la suite